| Bioactivity | STL427944 is a potent and selective FOXM1 inhibitor. STL427944 has the potential for the research of overcoming tumor chemoresistance and improving the efficacy of treatment with conventional cancer drug[1]. |
| CAS | 292028-62-7 |
| Formula | C25H23N7O4 |
| Molar Mass | 485.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chesnokov MS, et al. Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells. Cell Death Dis. 2021 Jul 14;12(7):704. |
STL427944
CAS: 292028-62-7 F: C25H23N7O4 W: 485.49
STL427944 is a potent and selective FOXM1 inhibitor. STL427944 has the potential for the research of overcoming tumor ch
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.